|
|
|
Volumn 283, Issue 5, 1999, Pages
|
|
The clinical-trials bottleneck.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
NEW DRUG;
ARTICLE;
ATTITUDE TO HEALTH;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
BREAST TUMOR;
COST BENEFIT ANALYSIS;
DECISION MAKING;
FINANCIAL MANAGEMENT;
HEALTH MAINTENANCE ORGANIZATION;
HUMAN;
HUMAN EXPERIMENT;
NATIONAL CANCER INSTITUTE;
NEOPLASM;
PATIENT;
PATIENT ADVOCACY;
PATIENT SELECTION;
PHYSICIAN;
POPULAR APPROACH/SOURCE;
PROBABILITY;
PROFESSIONAL STANDARD;
RADIATION;
RANDOMIZATION;
REIMBURSEMENT;
RESEARCH;
RESEARCH SUBJECT;
RISK;
RISK ASSESSMENT;
UNCERTAINTY;
UNITED STATES;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
NATIONAL CANCER INSTITUTE;
POPULAR APPROACH/SOURCE;
BREAST NEOPLASMS;
COST-BENEFIT ANALYSIS;
DECISION MAKING;
DRUGS, INVESTIGATIONAL;
ETHICS COMMITTEES;
ETHICS COMMITTEES, RESEARCH;
FINANCING, GOVERNMENT;
HEALTH KNOWLEDGE, ATTITUDES, PRACTICE;
HEALTH MAINTENANCE ORGANIZATIONS;
HUMAN EXPERIMENTATION;
HUMANS;
INSURANCE, HEALTH, REIMBURSEMENT;
NEOPLASMS;
NONTHERAPEUTIC HUMAN EXPERIMENTATION;
PATIENT ADVOCACY;
PATIENT SELECTION;
PATIENTS;
PHYSICIANS;
PROBABILITY;
RADIATION;
RANDOM ALLOCATION;
RESEARCH;
RESEARCH SUBJECTS;
RISK;
RISK ASSESSMENT;
THERAPEUTIC HUMAN EXPERIMENTATION;
UNCERTAINTY;
UNITED STATES;
|
|
EID: 0033122760
PISSN: 10727825
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (9)
|
|
References (0)
|
